Retrospective analysis of the use of cyclosporine in myasthenia gravis

Neurology

Volumn 55, Issue 3, 2000, Pages 448-450

  Ciafaloni, Emma ^a   Nikhar, Nirjaleshwar K ^a   Massey, Janice M ^a   Sanders, Donald B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN;

ADULT; AGED; ARTICLE; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0033849099     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.3.448     Document Type: Article

References (8)

1. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis
2. Myasthenia gravis treated with cyclosporine
3. Results of a one-year open trial of cyclosporine in ten patients with severe myasthenia gravis
4. Results of an open trial of cyclosporine in a group of steroid dependent myasthenic subjects
5. Long-term cyclosporine treatment in a group of severe myasthenia gravis patients
6. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Inc. Myasthenia gravis: Recommendations for clinical research standards
7. Single-fiber electromyography in myasthenia gravis
8. Cyclosporine induces cancer progression by a cell-autonomous mechanism